Literature DB >> 17525860

The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis.

Michael Lim1, Peter Sagar, A Abdulgader, Dinesh Thekkinkattil, Dermot Burke.   

Abstract

PURPOSE: We studied preoperative and perioperative factors with particular attention to the role of immunomodulatory medication, which may impact the incidence of pouch-related septic complications.
METHODS: A retrospective review of data from patients who underwent ileal pouch surgery during a 20-year period from 1985 to 2005 was performed. Preoperative use of immunomodulatory medication along with perioperative clinical, surgical, and disease variables were recorded. Patients were monitored for pouch-related sepsis in the early (within 30 days of surgery) and late (after 30 days of surgery) postoperative periods. Univariate and multivariate logistic regression analysis was performed.
RESULTS: There were 445 patients (206 females; 46.4 percent). Median age was 36 (interquartile range, 27-46) years. Median follow-up period was 52 (interquartile range, 26-86) months. Complete data were available for 335 patients. Early sepsis was seen in 58 patients (17.3 percent). Another 22 patients (6.5 percent) developed late sepsis. On multivariate analysis, only steroid use remained predictive of higher rates of early sepsis (odds ratio, 1.81; 95 percent confidence interval, 1.02-3.45; P=0.002). Likewise on multivariate analysis, both male gender (odds ratio, 0.24; 95 percent confidence interval, 0.09-0.71; P=0.007) and 5-aminosalicylic-acid use (odds ratio, 0.22; 95 percent confidence interval, 0.08-0.76; P=0.023) remained predictive of lower rates of sepsis.
CONCLUSIONS: Preoperative steroid use is associated with higher rates of early but not late pouch-related septic complications. We recommend that patients be weaned of steroids before ileal pouch surgery or be warned of the higher risk of postoperative sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525860     DOI: 10.1007/s10350-007-0246-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Surgical management of ulcerative colitis: a comparison of Canadian and American colorectal surgeons.

Authors:  Devon Richardson; Sandra deMontbrun; Paul M Johnson
Journal:  Can J Surg       Date:  2011-08       Impact factor: 2.089

2.  Surgical site infection and validity of staged surgical procedure in emergent/urgent surgery for ulcerative colitis.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Hiroki Matsuoka; Yoshiko Takahashi; Naohiro Tomita; Yoshio Takesue
Journal:  Int Surg       Date:  2013 Jan-Mar

3.  Surgical outcomes of Korean ulcerative colitis patients with and without colitis-associated cancer.

Authors:  Yong Sik Yoon; Yong Beom Cho; Kyu Joo Park; Seung Hyuk Baik; Sang Nam Yoon; Seung-Bum Ryoo; Kil Yeon Lee; Hungdai Kim; Ryung-Ah Lee; Chang Sik Yu
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis.

Authors:  Grace C Lee; Sarah E Deery; Hiroko Kunitake; Caitlin W Hicks; Adriana G Olariu; Lieba R Savitt; Ashwin N Ananthakrishnan; Rocco Ricciardi; Richard A Hodin; Liliana G Bordeianou
Journal:  Int J Colorectal Dis       Date:  2019-01-04       Impact factor: 2.571

Review 5.  [Perioperative handling of immunosuppressive therapy].

Authors:  J Wagner; V Luber; J F Lock; U A Dietz; S Lichthardt; N Matthes; K Krajinovic; C-T Germer; S Knop; A Wiegering
Journal:  Chirurg       Date:  2018-02       Impact factor: 0.955

Review 6.  The Role of Temporary Fecal Diversion.

Authors:  Amy L Lightner; John H Pemberton
Journal:  Clin Colon Rectal Surg       Date:  2017-05-22

7.  Long-term direct costs before and after proctocolectomy for ulcerative colitis: a population-based study in Olmsted County, Minnesota.

Authors:  Stefan D Holubar; Kirsten Hall Long; Edward V Loftus; Bruce G Wolff; John H Pemberton; Robert R Cima
Journal:  Dis Colon Rectum       Date:  2009-11       Impact factor: 4.585

8.  Does infliximab increase complications after surgery for inflammatory bowel disease?

Authors:  Stefan D Holubar; Robert R Cima; John H Pemberton
Journal:  F1000 Med Rep       Date:  2009-01-21

9.  Infliximab administration prior to surgery does not increase surgical site infections in patients with ulcerative colitis.

Authors:  Motoi Uchino; Hiroki Ikeuchi; Hiroki Matsuoka; Toshihiro Bando; Kaoru Ichiki; Kazuhiko Nakajima; Naohiro Tomita; Yoshio Takesue
Journal:  Int J Colorectal Dis       Date:  2013-04-21       Impact factor: 2.571

10.  Does intramesorectal proctectomy with rectal eversion affect postoperative complications compared to standard total mesorectal excision in patients with ulcerative colitis?

Authors:  Caitlin W Hicks; Richard A Hodin; Lieba Savitt; Liliana Bordeianou
Journal:  J Gastrointest Surg       Date:  2013-10-22       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.